OUR MEDICAL SPECIALISTS  >  DEPARTMENT OF THORACIC SURGERY & NATIONAL CANCER CENTER

Academician He Jie, MD, PhD

Member, Chinese Academy of Sciences · Director of National Cancer Center  |  Cancer Hospital, Chinese Academy of Medical Sciences (CICAMS)

Academician He Jie, MD, PhD
MEMBER, CHINESE ACADEMY OF SCIENCES · DIRECTOR OF NATIONAL CANCER CENTER

Academician He Jie, MD, PhD

Department of Thoracic Surgery & National Cancer Center
Cancer Hospital, Chinese Academy of Medical Sciences (CICAMS)
  • Hospital Affiliation
    Cancer Hospital, Chinese Academy of Medical Sciences (CICAMS)
  • Clinical Specialty
    Thoracic Surgical Oncology, Esophageal & Complex Lung Cancer
  • Clinical Languages
    English, Mandarin
  • Clinical Experience
    36+ Years
  • Consultation Turnaround
    24–48 Hours Priority Review
Request Specialist Review →
ACCREDITED CHAIR PROFILE & CLINICAL OVERVIEW

Supreme Authority in Thoracic Surgery and National Oncology Governance

Academician He Jie, MD, PhD, is a Member of the Chinese Academy of Sciences, Director of the National Cancer Center of China, and Director of the Cancer Hospital, Chinese Academy of Medical Sciences (CICAMS). He is recognized across the global surgical community as the foremost supreme authority in thoracic oncology, esophageal cancer, and complex pulmonary resection.

Academician He has pioneered surgical innovations that set modern benchmarks across Asia and Europe. He established standardized minimally invasive three-incision (McKeown) esophagectomy with radical three-field lymphadenectomy, complex broncho-angioplasty (double-sleeve lobectomy), and robotic-assisted thoracic surgery for mediastinal tumors, achieving surgical mortality rates below 0.5% in extreme-difficulty procedures.

As head of China's National Cancer Center, Academician He directs the formulation of National Clinical Practice Guidelines for Esophageal and Lung Carcinoma. His landmark clinical research on early esophageal cancer screening, neoadjuvant chemo-immunotherapy surgical downstaging, and perioperative outcomes has been published in *The Lancet Oncology*, *Annals of Surgery*, and *Journal of Clinical Oncology*.

Primary Appointment Director, National Cancer Center of China; Director, Cancer Hospital, CAMS (CICAMS)
Academic Distinction Member, Chinese Academy of Sciences (Elected 2013)
National Governance President, Thoracic Oncology Branch of Chinese Medical Association
Global Affiliations Fellow, American Association for Thoracic Surgery (AATS); Honorary Fellow, Royal College of Surgeons
CORE OPERATIVE MASTERY & CLINICAL EXCELLENCE

Procedural Frontiers & Department Innovations

Minimally Invasive McKeown Esophagectomy

Standardized thoracoscopic and laparoscopic three-incision esophagectomy with meticulous recurrent laryngeal nerve lymph node clearance.

Broncho-Vascular Double Sleeve Lobectomy

Simultaneous reconstruction of both main pulmonary artery and bronchus, completely resecting central tumors while avoiding pneumonectomy.

Neoadjuvant Chemo-IO Conversion Surgery

Achieving radical R0 resections in previously fixed T4b/N2 thoracic tumors post neoadjuvant PD-1 combinations with excellent wound healing.

Complex Superior Sulcus & Mediastinal Tumors

Specializes in Pancoast tumors involving the subclavian vessels and anterior mediastinal thymomas with superior vena cava replacement.

ACADEMIC AWARDS & LANDMARK TREATISES

Distinguished National & International Recognition

CAS MEMBER
Elected Member of Chinese Academy of Sciences
China's highest national lifetime scientific honor for clinical surgery and oncological science.
LANCET ONCOL
Nationwide Survival Trends & Screening Impact in Esophageal Cancer
Global milestone study evaluating endoscopic screening efficacy across high-incidence cohorts.
ANN SURG
Minimally Invasive vs. Open Esophagectomy Outcomes
Definitive multi-center prospective trial proving decreased pulmonary morbidity with equal oncologic cure.
NATIONAL AWARD
National Science & Technology Progress Award (1st Class)
China's highest government award for groundbreaking contributions to esophageal cancer prevention and cure.

CASE INTAKE & THORACIC SURGICAL TRIAGE

Request a Thoracic Surgical Review with Academician He Jie, MD, PhD

Submit contrast chest/upper abdominal CT/PET-CT DICOM scans, upper GI endoscopy reports with biopsy pathology, and cardiopulmonary PFT tests for direct surgical feasibility review by Academician He Jie. Our team responds within 24–48 hours.

    Academician He Jie, MD, PhD